CLASSYS Inc. (KOSDAQ:214150)
South Korea · Delayed Price · Currency is KRW 58,400
-500 (-0.85%)
At close: Feb 27, 2026
CLASSYS Revenue
In the year 2025, CLASSYS had annual revenue of 336.80B KRW with 38.64% growth. CLASSYS had revenue of 93.40B in the quarter ending December 31, 2025, with 25.53% growth.
Revenue
336.80B
Revenue Growth
+38.64%
P/S Ratio
11.33
Revenue / Employee
854.82M
Employees
394
Market Cap
3.82T
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 336.80B | 93.86B | 38.64% |
| Dec 31, 2024 | 242.94B | 62.82B | 34.87% |
| Dec 31, 2023 | 180.12B | 38.32B | 27.02% |
| Dec 31, 2022 | 141.80B | 41.21B | 40.96% |
| Dec 31, 2021 | 100.60B | 24.14B | 31.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Value Added Technology | 413.76B |
| Vieworks | 230.52B |
| T&L Co., Ltd. | 177.27B |
| BioNote | 115.09B |
| Dongbang Medical | 111.86B |
| Shinhung | 98.94B |
| PCL, Inc. | 4.98B |
| EOFLOW | 3.98B |